FDA-approved uses Wegovy : When paired with a healthy lifestyle, balanced and reduced-calorie diet, and exercise, Wegovy is FDA-approved for chronic weight management in patients with: Obesity (body mass index 30 kg/m or greater) or Overweight (body mass index 27 kg/m or greater) with at least one health condition that occurs due to increased body weight such as high blood pressure (hypertension), type 2 diabetes, hypercholesterolemia (high cholesterol levels), and heart disease, Its also FDA-approved for reducing the risk of major adverse cardiovascular events
This is where Ive shifted my own practice
This was done by employing an engineered cyst(e)inase enzyme resulting in the suppression of tumor growth in breast and prostate cancer xenografts (53)
Druckers data were published a few months later, in May
The three-way comparison between semaglutide, tirzepatide, and retatrutide consistently shows retatrutide at the top for total body weight percentage lost, and the difference becomes more pronounced at higher doses and longer treatment durations